FDA Approval Insights: Avapritinib in Indolent Systemic Mastocytosis

0 Mga view· 07/10/23
OncLive® On Air
OncLive® On Air
0 Mga subscriber
0
Sa

Dr Gotlib discusses the significance of the FDA approval of avapritinib in indolent systemic mastocytosis, key findings from the PIONEER trial, and the quality of life benefits that avapritinib provides for patients in this population.

Magpakita ng higit pa

 0 Mga komento sort   Pagbukud-bukurin Ayon


Susunod